Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Krynica VitaminWAR:KVT 70 Debt-to-EBITDA is 1.59 as of Mar. 2026, which is 25% below its 10-year median of 2.12. GuruFocus rates WAR:KVT with a GF Score™ of 70/100 and a GF Value™ of zł10.40 (Modestly Overvalued). The stock has 8 warning signs investors should review. Among 97 Beverages - Non-Alcoholic companies, Krynica Vitamin ranks better than 59.79% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Krynica Vitamin's Debt-to-EBITDA or its related term are showing as below:
WAR:KVT'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.45 Med: 2.12 Max: 5.34
Current: 0.94
During the past 12 years, the highest Debt-to-EBITDA Ratio of Krynica Vitamin was 5.34. The lowest was 0.45. And the median was 2.12.
WAR:KVT's Debt-to-EBITDA is ranked better than 59.79% of 97
companies
in the Beverages - Non-Alcoholic industry
Industry Median: 1.26
vs WAR:KVT: 0.94
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Krynica Vitamin Debt-to-EBITDA Related Terms
Krynica Vitamin Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Krynica Vitamin's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WAR:KVT vs KO, PEP, MNST: Debt-to-EBITDA Comparison
For the Beverages - Non-Alcoholic subindustry, Krynica Vitamin's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Krynica Vitamin Debt-to-EBITDA vs Beverages - Non-Alcoholic Industry
For the Beverages - Non-Alcoholic industry and Consumer Defensive sector, Krynica Vitamin's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Krynica Vitamin's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Mar. 2026) EBITDA data.
Krynica Vitamin (WAR:KVT) has a Debt-to-EBITDA of 1.59 as of Mar. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Krynica Vitamin. This is 25% below median its historical median of 2.12. Over the past decade, Krynica Vitamin's Debt-to-EBITDA has ranged from 0.45 to 5.34. According to the industry distribution chart, Krynica Vitamin ranks #39 out of 97 companies in the Beverages - Non-Alcoholic industry, placing it in the top 40.2%.
Is Krynica Vitamin's Debt-to-EBITDA too high?
Krynica Vitamin's current Debt-to-EBITDA of 1.59 is 25% below median its 10-year median of 2.12. Over the past 10 years, this metric has ranged from a low of 0.45 to a high of 5.34. The Beverages - Non-Alcoholic industry median Debt-to-EBITDA is 1.26. Krynica Vitamin's value of 1.59 is 26.2% above this industry median. Based on the distribution chart, Krynica Vitamin ranks #39 out of 97 companies in the Beverages - Non-Alcoholic industry, which is above the industry midpoint. Overall, Krynica Vitamin has a GF Score™ of 70/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Krynica Vitamin's Debt-to-EBITDA compare to KO and PEP?
According to the Beverages - Non-Alcoholic industry distribution chart, Krynica Vitamin ranks #39 out of 97 companies for Debt-to-EBITDA. This puts Krynica Vitamin in the upper half of its industry. The industry median Debt-to-EBITDA is 1.26. Krynica Vitamin's value of 1.59 is 26.2% above this benchmark. Historically, Krynica Vitamin's own Debt-to-EBITDA has ranged from 0.45 to 5.34 over the past decade. While the company's 10-year median is 2.12 vs. the industry median of 1.26, Krynica Vitamin has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Beverages - Non-Alcoholic company?
The median Debt-to-EBITDA among Beverages - Non-Alcoholic companies is 1.26, based on 97 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Krynica Vitamin's current Debt-to-EBITDA of 1.59 is 26.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Krynica Vitamin. For the Beverages - Non-Alcoholic industry, the median Debt-to-EBITDA is 1.26 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Krynica Vitamin's current Debt-to-EBITDA is 1.59, which is 25% below median its own 10-year median of 2.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Krynica Vitamin stock overvalued right now?
Based on GuruFocus' analysis, Krynica Vitamin (WAR:KVT) is currently considered Modestly Overvalued. The stock's GF Value™ is zł10.40, compared to a current price of zł13.05 — trading 25.5% above its estimated fair value. The current Debt-to-EBITDA is 1.59, which is 25% below median its 10-year median of 2.12 and 26.2% above the Beverages - Non-Alcoholic industry median of 1.26. Krynica Vitamin's overall GF Score™ is 70/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Krynica Vitamin (WAR:KVT), the current Debt-to-EBITDA is 1.59 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Krynica Vitamin (WAR:KVT) Overvalued in 2026?
Based on GuruFocus' analysis, Krynica Vitamin stock appears to be overvalued.
The current stock price of zł13.05 is trading 25.5% above its estimated GF Value™ of zł10.40.
GuruFocus considers Krynica Vitamin to be Modestly Overvalued.
Key valuation signals for WAR:KVT:
Debt-to-EBITDA: 1.59 (25% below median its 10-year median of 2.12)
GF Value™: zł10.40 vs. price of zł13.05 (25.5% above fair value)
Industry Position: 26.2% above the Beverages - Non-Alcoholic median (#39 of 97)
No single metric tells the full story. See the WAR:KVT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Krynica Vitamin SA is a Polish producer of non-alcoholic and low-alcoholic beverages. The company is engaged in producing beverages for own brands and providing bottling services for brand-name products. It offer includes functional and energy drinks such as isotonic and hypotonic drinks, beverages that support metabolism, and diet supplementary vitamin drinks. It also offers functional waters, modern mixed-fruit drinks, drinks with fruit pulp, alcopops, ciders, malt beverages and a wide selection of carbonated beverages.
70GF Score
Get the complete analysis for WAR:KVT
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:KVT has been successfully added to your 
